과제정보
This work was supported by "Study on the role and mechanism of long non-coding RNA ENRPD1-AS1 mediating the up-regulation of METTL3 expression in promoting gastric cancer" (2021KY250).
참고문헌
- Niu Y, Zhang J, Tong Y, Li J, Liu B. 2019. Physcion 8-O-β-glucopyranoside induced ferroptosis via regulating miR-103a-3p/GLS2 axis in gastric cancer. Life Sci. 237: 116893.
- Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. 2020. Gastric cancer. Lancet (London, England) 396: 635-648. https://doi.org/10.1016/S0140-6736(20)31288-5
- Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. 2014. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol. Biomarkers Prev. 23: 700-713. https://doi.org/10.1158/1055-9965.EPI-13-1057
- Lordick F, Hoffmeister A. 2014. [Treatment of gastric cancer]. Der Internist 55: 15-16, 18-22. https://doi.org/10.1007/s00108-013-3317-5
- Necula L, Matei L, Dragu D, Neagu AI, Mambet C, Nedeianu S, et al. 2019. Recent advances in gastric cancer early diagnosis. World J. Gastroenterol. 25: 2029-2044. https://doi.org/10.3748/wjg.v25.i17.2029
- Li B, Zhu L, Lu C, Wang C, Wang H, Jin H, et al. 2021. circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity. Nat. Commun. 12: 295.
- Xia Y, Lv J, Jiang T, Li B, Li Y, He Z, et al. 2021. CircFAM73A promotes the cancer stem cell-like properties of gastric cancer through the miR-490-3p/HMGA2 positive feedback loop and HNRNPK-mediated β-catenin stabilization. J. Exp. Clin. Cancer Res. CR. 40: 103.
- Cao J, Zhang X, Xu P, Wang H, Wang S, Zhang L, et al. 2021. Circular RNA circLMO7 acts as a microRNA-30a-3p sponge to promote gastric cancer progression via the WNT2/β-catenin pathway. J. Exp. Clin. Cancer Res. 40: 6.
- Dai X, Liu J, Guo X, Cheng A, Deng X, Guo L, et al. 2020. Circular RNA circFGD4 suppresses gastric cancer progression via modulating miR-532-3p/APC/β-catenin signalling pathway. Clin. Sci. London 134: 1821-1839. https://doi.org/10.1042/CS20191043
- Wei T, Ye P, Yu GY, Zhang ZY. 2020. Circular RNA expression profiling identifies specific circular RNAs in tongue squamous cell carcinoma. Mol. Med. Rep. 21: 1727-1738.
- Rong L, Huang W, Tian S, Chi X, Zhao P, Liu F. 2018. COL1A2 is a novel biomarker to improve clinical prediction in human gastric cancer: Integrating bioinformatics and meta-analysis. Pathol. Oncol. Res. 24: 129-134. https://doi.org/10.1007/s12253-017-0223-5
- Ao R, Guan L, Wang Y, Wang JN. 2018. Silencing of COL1A2, COL6A3, and THBS2 inhibits gastric cancer cell proliferation, migration, and invasion while promoting apoptosis through the PI3k-Akt signaling pathway. J. Cell. Biochem. 119: 4420-4434. https://doi.org/10.1002/jcb.26524
- Hong M, Tao S, Zhang L, Diao LT, Huang X, Huang S, et al. 2020. RNA sequencing: new technologies and applications in cancer research. J. Hematol. Oncol. 13: 166.
- Tao Z, Shi A, Li R, Wang Y, Wang X, Zhao J. 2017. Microarray bioinformatics in cancer- a review. J. BUON 22: 838-843.
- Chen Y, Li H, Ding T, Li J, Zhang Y, Wang J, et al. 2020. Lnc-M2 controls M2 macrophage differentiation via the PKA/CREB pathway. Mol. Immunol. 124: 142-152. https://doi.org/10.1016/j.molimm.2020.06.006
- Yuan S, Si W, Zhuang K, Li Y, Zhang Y, Liu J, et al. 2021. LncRNA UCID Promotes hepatocellular carcinoma metastasis via stabilization of snail. OncoTargets Ther. 14: 725-736. https://doi.org/10.2147/OTT.S277951
- Hu YP, Jin YP, Wu XS, Yang Y, Li YS, Li HF, et al. 2019. LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p/SET/AKT axis. Mol. Cancer 18: 167.
- Wang LQ, Zheng YY, Zhou HJ, Zhang XX, Wu P, Zhu SM. 2021. LncRNA-Fendrr protects against the ubiquitination and degradation of NLRC4 protein through HERC2 to regulate the pyroptosis of microglia. Mol. Med. 27: 39.
- Sun Z, Ou C, Liu J, Chen C, Zhou Q, Yang S, et al. 2019. YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer. Oncogene 38: 2627-2644. https://doi.org/10.1038/s41388-018-0628-y
- Zhang Y, Jiang J, Zhang J, Shen H, Wang M, Guo Z, et al. 2021. CircDIDO1 inhibits gastric cancer progression by encoding a novel DIDO1-529aa protein and regulating PRDX2 protein stability. Mol. Cancer 20: 101.
- Qu J, Yang J, Chen M, Wei R, Tian J. 2020. CircFLNA acts as a sponge of miR-646 to facilitate the proliferation, metastasis, glycolysis, and apoptosis inhibition of gastric cancer by targeting PFKFB2. Cancer Manag. Res. 12: 8093-8103. https://doi.org/10.2147/CMAR.S264674
- Wang Z, Wang Z, Li G, Wu H, Sun K, Chen J, et al. 2017. CXCL1 from tumor-associated lymphatic endothelial cells drives gastric cancer cell into lymphatic system via activating integrin β1/FAK/AKT signaling. Cancer Lett. 385: 28-38. https://doi.org/10.1016/j.canlet.2016.10.043
- Lee SW, Park DY, Kim MY, Kang C. 2019. Synergistic triad epistasis of epigenetic H3K27me modifier genes, EZH2, KDM6A, and KDM6B, in gastric cancer susceptibility. Gastric Cancer 22: 640-644. https://doi.org/10.1007/s10120-018-0888-9
- Gou WF, Shen DF, Yang XF, Zhao S, Liu YP, Sun HZ, et al. 2015. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression. Oncotarget 6: 19552-19579. https://doi.org/10.18632/oncotarget.3735
- Liu X, Chu KM. 2017. α-Actinin-4 promotes metastasis in gastric cancer. Lab. Invest. 97: 1084-1094. https://doi.org/10.1038/labinvest.2017.28
- Cheng LL, Itahana Y, Lei ZD, Chia NY, Wu Y, Yu Y, et al. 2012. TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep). Clin. Cancer Res. 18: 4201-4212. https://doi.org/10.1158/1078-0432.CCR-12-0036
- Zeng Z, Wu HX, Zhan N, Huang YB, Wang ZS, Yang GF, et al. 2014. Prognostic significance of USP10 as a tumor-associated marker in gastric carcinoma. Tumour Biol. 35: 3845-3853. https://doi.org/10.1007/s13277-013-1509-1
- Li Y, Gan S, Ren L, Yuan L, Liu J, Wang W, et al. 2018. Multifaceted regulation and functions of replication factor C family in human cancers. Am. J. Cancer Res. 8: 1343-1355.
- Zhu H, Yan F, Yuan T, Qian M, Zhou T, Dai X, et al. 2020. USP10 Promotes proliferation of hepatocellular carcinoma by deubiquitinating and stabilizing YAP/TAZ. Cancer Res. 80: 2204-2216.
- Sun J, Li T, Zhao Y, Huang L, Sun H, Wu H, et al. 2018. USP10 inhibits lung cancer cell growth and invasion by upregulating PTEN. Mol. Cell. Bochem. 441: 1-7. https://doi.org/10.1007/s11010-017-3170-2
- Ko A, Han SY, Choi CH, Cho H, Lee MS, Kim SY, et al. 2018. Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF. Cell Death Differ. 25: 1050-1062. https://doi.org/10.1038/s41418-018-0072-0
- Ouyang SW, Liu TT, Liu XS, Zhu FX, Zhu FM, Liu XN, et al. 2019. USP10 regulates Musashi-2 stability via deubiquitination and promotes tumour proliferation in colon cancer. FEBS Lett. 593: 406-413. https://doi.org/10.1002/1873-3468.13323
- Hu T, Shen H, Li J, Yang P, Gu Q, Fu Z. 2020. RFC2, a direct target of miR-744, modulates the cell cycle and promotes the proliferation of CRC cells. J. Cell. Physiol. 235: 8319-8333. https://doi.org/10.1002/jcp.29676
- Ji Z, Li J, Wang J. 2021. Up-regulated RFC2 predicts unfavorable progression in hepatocellular carcinoma. Hereditas 158: 17.